French Authority Fines J&J €25 Million for Blocking Generics

Drug Industry Daily
A A
The French Competition Authority fined Johnson & Johnson €25 million ($27 million) for delaying market access to generic copies of its painkiller Durogesic, a fentanyl-based patch for treatment of chronic and severe pain.

To View This Article:

Login

Subscribe To Drug Industry Daily